Ngā hua rapu - Ina Müller

  • E whakaatu ana i te 1 - 5 hua o te 5
Whakamahine hua
  1. 1
    A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes

    A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes mā Niels Schaft, Jan Dörrie, Ina Müller, Verena Beck, Stefanie Baumann, Tanja Schunder, Eckhart Kämpgen, Gerold Schuler

    I whakaputaina 2005
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation

    Generation of an Optimized Polyvalent Monocyte-Derived Dendritic Cell Vaccine by Transfecting Defined RNAs after Rather Than before Maturation mā Niels Schaft, Jan Dörrie, Peter Thumann, Verena Beck, Ina Müller, Erwin Schultz, Eckhart Kämpgen, Detlef Dieckmann, Gerold Schuler

    I whakaputaina 2005
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies

    Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies mā Ilka Knippertz, Marcello F. Stein, Jan Dörrie, Niels Schaft, Ina Müller, Andrea Deinzer, Alexander Steinkasserer, Dirk M. Nettelbeck

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survival

    Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and... mā Nikolai Siebert, Christian Fuglesang S. Jensen, Sascha Troschke‐Meurer, Maxi Zumpe, Madlen Jüttner, Karoline Ehlert, Silke Kietz, Ina Müller, Holger N. Lode

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (ACIMM)

    Combination chemotherapy with or without s.c. IL-2 and IFN-α: results of a prospectively randomized trial of the Cooperative Advanced Malignant Melanoma Chemoimmunotherapy Group (A... mā Jens Atzpodien, K. Neuber, Darab Kamanabrou, Michael Fluck, E B Bröcker, C. Neumann, Thomas M. Rünger, Gerold Schuler, Peter Von Den Driesch, Ina Müller, E. Paul, T Patzelt, Martina Reitz

    I whakaputaina 2002
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: